The low-risk papillomaviruses

Virus Research

Volumn 231, Issue , 2017, Pages 119-127

  Egawa, Nagayasu ^a   Doorbar, John ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

HPV; Papilloma; Papillomatosis; Papillomavirus; Wart

Indexed keywords

VIRAL PROTEIN; ONCOPROTEIN;

ASYMPTOMATIC INFECTION; CANCER GROWTH; CARCINOGENESIS; GENE EXPRESSION; HUMAN; INFECTION RISK; MALIGNANT TRANSFORMATION; NONHUMAN; PAPILLOMA; PAPILLOMATOSIS; PAPILLOMAVIRUS INFECTION; PREVALENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; VIRUS GENE; VIRUS GENOME; ASYMPTOMATIC DISEASE; CLASSIFICATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HOST PATHOGEN INTERACTION; METABOLISM; PAPILLOMAVIRIDAE; PATHOGENICITY; PATHOLOGY; PHYLOGENY; RISK; SKIN TUMOR; VERRUCA VULGARIS; VIROLOGY;

ASYMPTOMATIC DISEASES; CARCINOGENESIS; GENE EXPRESSION; GENOME, VIRAL; HOST-PATHOGEN INTERACTIONS; HUMANS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PHYLOGENY; RISK; SKIN NEOPLASMS; WARTS;

EID: 85009387527     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2016.12.017     Document Type: Review

References (106)

1. Alam, M., Caldwell, J.B., Eliezri, Y.D., Human papillomavirus-associated digital squamous cell carcinoma: literature review and report of 21 new cases. J. Am. Acad. Dermatol. 48:3 (2003), 385–393.
2. Antonsson, A., Erfurt, C., Hazard, K., Holmgren, V., Simon, M., Kataoka, A., Hossain, S., Hakangard, C., Hansson, B.G., Prevalence and type spectrum of human papillomaviruses in healthy skin samples collected in three continents. J. Gen. Virol. 84:Pt 7 (2003), 1881–1886.
3. Antonsson, A., Karanfilovska, S., Lindqvist, P.G., Hansson, B.G., General acquisition of human papillomavirus infections of skin occurs in early infancy. J. Clin. Microbiol. 41:6 (2003), 2509–2514.
4. Barrow-Laing, L., Chen, W., Roman, A., Low- and high-risk human papillomavirus E7 proteins regulate p130 differently. Virology 400:2 (2010), 233–239.
5. Bernard, H.U., Burk, R.D., Chen, Z., van Doorslaer, K., zur Hausen, H., de Villiers, E.M., Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 401:1 (2010), 70–79.
6. Bodily, J.M., Hennigan, C., Wrobel, G.A., Rodriguez, C.M., Regulation of the human papillomavirus type 16 late promoter by E7 and the cell cycle. Virology 443:1 (2013), 11–19.
7. Bonagura, V.R., Hatam, L.J., Rosenthal, D.W., de Voti, J.A., Lam, F., Steinberg, B.M., Abramson, A.L., Recurrent respiratory papillomatosis: a complex defect in immune responsiveness to human papillomavirus-6 and -11. APMIS 118:6–7 (2010), 455–470.
8. Bravo, I.G., Felez-Sanchez, M., Papillomaviruses: viral evolution, cancer and evolutionary medicine. Evolu. Med. Public Health 2015:1 (2015), 32–51.
9. Brimer, N., Lyons, C., Wallberg, A.E., Vande Pol, S.B., Cutaneous papillomavirus E6 oncoproteins associate with MAML1 to repress transactivation and NOTCH signaling. Oncogene 31:43 (2012), 4639–4646.
10. Broker, T.R., Jin, G., Croom-Rivers, A., Bragg, S.M., Richardson, M., Chow, L.T., Vermund, S.H., Alvarez, R.D., Pappas, P.G., Squires, K.E., Hoesley, C.J., Viral latency–the papillomavirus model. Dev. Biol. (Basel) 106 (2001), 443–451 discussion 452-443, 465–475.
11. Butz, K., Ristriani, T., Hengstermann, A., Denk, C., Scheffner, M., Hoppe-Seyler, F., siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells. Oncogene 22:38 (2003), 5938–5945.
12. Carifi, M., Napolitano, D., Morandi, M., Dall'Olio, D., Recurrent respiratory papillomatosis: current and future perspectives. Ther. Clin. Risk Manag. 11 (2015), 731–738.
13. Connolly, K., Manders, P., Earls, P., Epstein, R.J., Papillomavirus-associated squamous skin cancers following transplant immunosuppression: one Notch closer to control. Cancer Treat. Rev. 40:2 (2014), 205–214.
14. Cordano, P., Gillan, V., Bratlie, S., Bouvard, V., Banks, L., Tommasino, M., Campo, M.S., The E6E7 oncoproteins of cutaneous human papillomavirus type 38 interfere with the interferon pathway. Virology 377:2 (2008), 408–418.
15. Cornall, A.M., Roberts, J.M., Garland, S.M., Hillman, R.J., Grulich, A.E., Tabrizi, S.N., Anal and perianal squamous carcinomas and high-grade intraepithelial lesions exclusively associated with low-risk HPV genotypes 6 and 11. J. Int. du Cancer Journal international du cancer 133:9 (2013), 2253–2258.
16. DeSmet, M., Kanginakudru, S., Rietz, A., Wu, W.H., Roden, R., Androphy, E.J., The replicative consequences of papillomavirus E2 protein binding to the origin replication factor ORC2. PLoS Pathog., 12(10), 2016, e1005934.
17. Desai, S., Wetten, S., Woodhall, S.C., Peters, L., Hughes, G., Soldan, K., Genital warts and cost of care in England. Sex. Transm. Infect. 87:6 (2011), 464–468.
18. de Koning, M.N., Struijk, L., Bavinck, J.N., Kleter, B., ter Schegget, J., Quint, W.G., Feltkamp, M.C., Betapapillomaviruses frequently persist in the skin of healthy individuals. J. Gen. Virol. 88:Pt 5 (2007), 1489–1495.
19. de Koning, M.N., ter Schegget, J., Eekhof, J.A., Kamp, M., Kleter, B., Gussekloo, J., Feltkamp, M.C., Bouwes Bavinck, J.N., Purdie, K.J., Bunker, C.B., Proby, C.M., Meys, R., Harwood, C.A., Quint, W.G., Evaluation of a novel broad-spectrum PCR-multiplex genotyping assay for identification of cutaneous wart-associated human papillomavirus types. J. Clin. Microbiol. 48:5 (2010), 1706–1711.
20. de Koning, M.N., Quint, K.D., Bruggink, S.C., Gussekloo, J., Bouwes Bavinck, J.N., Feltkamp, M.C., Quint, W.G., Eekhof, J.A., High prevalence of cutaneous warts in elementary school children and the ubiquitous presence of wart-associated human papillomavirus on clinically normal skin. Brit. J. Dermatol. 172:1 (2015), 196–201.
21. de Villiers, E.M., Fauquet, C., Broker, T.R., Bernard, H.U., zur Hausen, H., Classification of papillomaviruses. Virology 324:1 (2004), 17–27.
22. Donne, A., Keltie, K., Cole, H., Sims, A., Patrick, H., Powell, S., Prevalence and management of Recurrent Respiratory Papillomatosis (RRP) in the UK: cross sectional study. Clin. Otolaryngol. 42 (2016), 86–91.
23. Doorbar, J., Quint, W., Banks, L., Bravo, I.G., Stoler, M., Broker, T.R., Stanley, M.A., The biology and life-cycle of human papillomaviruses. Vaccine 30:Supp. 5 (2012), F55–70.
24. Doorbar, J., Egawa, N., Griffin, H., Kranjec, C., Murakami, I., Human papillomavirus molecular biology and disease association. Rev. Med. Virol. 25:Suppl. 1 (2015), 2–23.
25. Doorbar, J., The E4 protein; structure, function and patterns of expression. Virology 445:1–2 (2013), 80–98.
26. Drolet, M., Benard, E., Boily, M.C., Ali, H., Baandrup, L., Bauer, H., Beddows, S., Brisson, J., Brotherton, J.M., Cummings, T., Donovan, B., Fairley, C.K., Flagg, E.W., Johnson, A.M., Kahn, J.A., Kavanagh, K., Kjaer, S.K., Kliewer, E.V., Lemieux-Mellouki, P., Markowitz, L., Mboup, A., Mesher, D., Niccolai, L., Oliphant, J., Pollock, K.G., Soldan, K., Sonnenberg, P., Tabrizi, S.N., Tanton, C., Brisson, M., Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect. Dis. 15:5 (2015), 565–580.
27. Duensing, S., Munger, K., Mechanisms of genomic instability in human cancer: insights from studies with human papillomavirus oncoproteins. Int. J. Cancer J. Int. du cancer 109:2 (2004), 157–162.
28. Egawa, K., Inaba, Y., Yoshimura, K., Ono, T., Varied clinical morphology of HPV-1-induced warts, depending on anatomical factors. B. J. Dermatol. 128 (1993), 271–276.
29. Egawa, K., Iftner, A., Doorbar, J., Honda, Y., Iftner, T., Synthesis of viral DNA and late capsid protein L1 in parabasal spinous cell layers of naturally occurring benign warts infected with human papillomavirus type 1. Virology 268:2 (2000), 281–293.
30. Egawa, N., Nakahara, T., Ohno, S., Narisawa-Saito, M., Yugawa, T., Fujita, M., Yamato, K., Natori, Y., Kiyono, T., The E1 protein of human papillomavirus type 16 is dispensable for maintenance replication of the viral genome. J. Virol. 86:6 (2012), 3276–3283.
31. Egawa, N., Egawa, K., Griffin, H., Doorbar, J., Human papillomaviruses; epithelial tropisms, and the development of neoplasia. Viruses 7:7 (2015), 3863–3890.
32. Egawa, K., Do human papillomaviruses target epidermal stem cells?. Dermatology 207:3 (2003), 251–254.
33. Evans, M.F., Peng, Z., Clark, K.M., Adamson, C.S., Ma, X.J., Wu, X., Wang, H., Luo, Y., Cooper, K., HPV E6/E7 RNA in situ hybridization signal patterns as biomarkers of three-tier cervical intraepithelial neoplasia grade. PLoS One, 9(3), 2014, e91142.
34. Flores, E.R., Lambert, P.F., Evidence for a switch in the mode of human papillomavirus type 16 DNA replication during the viral life cycle. J. Virol. 71:10 (1997), 7167–7179.
35. Forslund, O., Iftner, T., Andersson, K., Lindelof, B., Hradil, E., Nordin, P., Stenquist, B., Kirnbauer, R., Dillner, J., de Villiers, E.M., Viraskin Study, G., Cutaneous human papillomaviruses found in sun-exposed skin: beta-papillomavirus species 2 predominates in squamous cell carcinoma. J. Infect. Dis. 196:6 (2007), 876–883.
36. Fu, L., Van Doorslaer, K., Chen, Z., Ristriani, T., Masson, M., Trave, G., Burk, R.D., Degradation of p53 by human Alphapapillomavirus E6 proteins shows a stronger correlation with phylogeny than oncogenicity. PLoS One, 5(9), 2010.
37. Ganti, K., Broniarczyk, J., Manoubi, W., Massimi, P., Mittal, S., Pim, D., Szalmas, A., Thatte, J., Thomas, M., Tomaic, V., Banks, L., The human papillomavirus E6 PDZ binding motif: from life cycle to malignancy. Viruses 7:7 (2015), 3530–3551.
38. Gerein, V., Rastorguev, E., Gerein, J., Draf, W., Schirren, J., Incidence, age at onset, and potential reasons of malignant transformation in recurrent respiratory papillomatosis patients: 20 years experience. Otolaryngol. Head Neck Surg. 132:3 (2005), 392–394.
39. Ginsberg, H.S., Dixon, M.K., Nucleuc acid synthesis in types 4 and 5 adenovirus-infected HeLa cells. J. Exp. Med. 113 (1961), 283–299.
40. Goon, P., Sonnex, C., Jani, P., Stanley, M., Sudhoff, H., Recurrent respiratory papillomatosis: an overview of current thinking and treatment. Eur. Arch. Oto-Rhino-Laryngol. 265:2 (2008), 147–151.
41. Guimera, N., Lloveras, B., Alemany, L., Iljazovic, E., Shin, H.R., Jung-Il, S., de Sanjose, S., Jenkins, D., Bosch, F.X., Quint, W., Laser capture microdissection shows HPV11 as both a causal and a coincidental infection in cervical cancer specimens with multiple HPV types. Histopathology 63:2 (2013), 287–292.
42. Guimera, N., Lloveras, B., Lindeman, J., Alemany, L., van de Sandt, M., Alejo, M., Hernandez-Suarez, G., Bravo, I.G., Molijn, A., Jenkins, D., Cubilla, A., Munoz, N., de Sanjose, S., Bosch, F.X., Quint, W., groups, R.H.T.V.s., The occasional role of low-risk human papillomaviruses 6, 11, 42, 44, and 70 in anogenital carcinoma defined by laser capture microdissection/PCR methodology: results from a global study. Am. J. Surg. Pathol. 37:9 (2013), 1299–1310.
43. Herfs, M., Yamamoto, Y., Laury, A., Wang, X., Nucci, M.R., McLaughlin-Drubin, M.E., Munger, K., Feldman, S., McKeon, F.D., Xian, W., Crum, C.P., A discrete population of squamocolumnar junction cells implicated in the pathogenesis of cervical cancer. Proc. Natl. Acad. Sci. U. S. A. 109:26 (2012), 10516–10521.
44. Herfs, M., Vargas, S.O., Yamamoto, Y., Howitt, B.E., Nucci, M.R., Hornick, J.L., McKeon, F.D., Xian, W., Crum, C.P., A novel blueprint for ‘top down’ differentiation defines the cervical squamocolumnar junction during development, reproductive life, and neoplasia. J. Pathol. 229:3 (2013), 460–468.
45. Hoffmann, R., Hirt, B., Bechtold, V., Beard, P., Raj, K., Different modes of human papillomavirus DNA replication during maintenance. J. Virol. 80:9 (2006), 4431–4439.
46. Howley, P.M., Pfister, H.J., Beta genus papillomaviruses and skin cancer. Virology 479:479–480 (2015), 290–296.
47. Huebbers, C.U., Preuss, S.F., Kolligs, J., Vent, J., Stenner, M., Wieland, U., Silling, S., Drebber, U., Speel, E.J., Klussmann, J.P., Integration of HPV6 and downregulation of AKR1C3 expression mark malignant transformation in a patient with juvenile-onset laryngeal papillomatosis. PLoS One, 8(2), 2013, e57207.
48. Hummel, M., Hudson, J.B., Laimins, L.A., Differentiation-induced and constitutive transcription of human papillomavirus type 31b in cell lines containing viral episomes. J. Virol. 66:10 (1992), 6070–6080.
49. Jackson, S., Storey, A., E6 proteins from diverse cutaneous HPV types inhibit apoptosis in response to UV damage. Oncogene 19:4 (2000), 592–598.
50. Jiang, M., Milner, J., Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference. Oncogene 21:39 (2002), 6041–6048.
51. Kim, K., Lambert, P.F., E1 protein of bovine papillomavirus 1 is not required for the maintenance of viral plasmid DNA replication. Virology 293:1 (2002), 10–14.
52. Lazarczyk, M., Pons, C., Mendoza, J.A., Cassonnet, P., Jacob, Y., Favre, M., Regulation of cellular zinc balance as a potential mechanism of EVER-mediated protection against pathogenesis by cutaneous oncogenic human papillomaviruses. J. Exp. Med. 205:1 (2008), 35–42.
53. Lazarczyk, M., Cassonnet, P., Pons, C., Jacob, Y., Favre, M., The EVER proteins as a natural barrier against papillomaviruses: a new insight into the pathogenesis of human papillomavirus infections. Microbiol. Mol. Biol. Rev. 73:2 (2009), 348–370.
54. Lazarczyk, M., Dalard, C., Hayder, M., Dupre, L., Pignolet, B., Majewski, S., Vuillier, F., Favre, M., Liblau, R.S., EVER proteins, key elements of the natural anti-human papillomavirus barrier, are regulated upon T-cell activation. PLoS One, 7(6), 2012, e39995.
55. Li, N., Franceschi, S., Howell-Jones, R., Snijders, P.J., Clifford, G.M., Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication. Int. J. Cancer J. Int. du cancer 128:4 (2011), 927–935.
56. Lutzner, M.A., Orth, G., Dutronquay, V., Ducasse, M.F., Kreis, H., Crosnier, J., Detection of human papillomavirus type 5 DNA in skin cancers of an immunosuppressed renal allograft recipient. Lancet 2:8347 (1983), 422–424.
57. Lutzner, M.A., Blanchet-Bardon, C., Orth, G., Clinical observations, virologic studies, and treatment trials in patients with epidermodysplasia verruciformis, a disease induced by specific human papillomaviruses. J. Invest. Dermatol. 83:Suppl. 1 (1984), 18s–25s.
58. Lutzner, M.A., Epidermodysplasia verruciformis. An autosomal recessive disease characterized by viral warts and skin cancer. A model for viral oncogenesis. Bull. Cancer (Paris) 65:2 (1978), 169–182.
59. Maglennon, G.A., McIntosh, P., Doorbar, J., Persistence of viral DNA in the epithelial basal layer suggests a model for papillomavirus latency following immune regression. Virology 414:2 (2011), 153–163.
60. Meyers, J.M., Spangle, J.M., Munger, K., The human papillomavirus type 8 E6 protein interferes with NOTCH activation during keratinocyte differentiation. J. Virol. 87:8 (2013), 4762–4767.
61. Mirkovic, J., Howitt, B.E., Roncarati, P., Demoulin, S., Suarez-Carmona, M., Hubert, P., McKeon, F.D., Xian, W., Li, A., Delvenne, P., Crum, C.P., Herfs, M., Carcinogenic HPV infection in the cervical squamo-columnar junction. J. Pathol. 236 (2015), 265–271.
62. Muench, P., Probst, S., Schuetz, J., Leiprecht, N., Busch, M., Wesselborg, S., Stubenrauch, F., Iftner, T., Cutaneous papillomavirus E6 proteins must interact with p300 and block p53-mediated apoptosis for cellular immortalization and tumorigenesis. Cancer Res. 70:17 (2010), 6913–6924.
63. Neveu, G., Cassonnet, P., Vidalain, P.O., Rolloy, C., Mendoza, J., Jones, L., Tangy, F., Muller, M., Demeret, C., Tafforeau, L., Lotteau, V., Rabourdin-Combe, C., Trave, G., Dricot, A., Hill, D.E., Vidal, M., Favre, M., Jacob, Y., Comparative analysis of virus-host interactomes with a mammalian high-throughput protein complementation assay based on Gaussia princeps luciferase. Methods 58:4 (2012), 349–359.
64. Notarangelo, L., Casanova, J.L., Fischer, A., Puck, J., Rosen, F., Seger, R., Geha, R., International Union of Immunological Societies Primary Immunodeficiency diseases classification, Primary immunodeficiency diseases: an update. J. Allergy Clin. Immunol. 114:3 (2004), 677–687.
65. Orth, G., Jablonska, S., Favre, M., Croissant, O., Jarzabek-Chorzelska, M., Rzesa, G., Characterization of two types of human papillomaviruses in lesions of epidermodysplasia verruciformis. Proc. Natl. Acad. Sci. U. S. A. 75:3 (1978), 1537–1541.
66. Orth, G., Genetics of epidermodysplasia verruciformis: insights into host defense against papillomaviruses. Semin. Immunol. 18:6 (2006), 362–374.
67. Ozbun, M.A., Meyers, C., Characterization of late gene transcripts expressed during vegetative replication of human papillomavirus type 31b. J. Virol. 71:7 (1997), 5161–5172.
68. Ozbun, M.A., Meyers, C., Human papillomavirus type 31b E1 and E2 transcript expression correlates with vegetative viral genome amplification. Virology 248:2 (1998), 218–230.
69. Petrik, D.T., Schmitt, K.P., Stinski, M.F., Inhibition of cellular DNA synthesis by the human cytomegalovirus IE86 protein is necessary for efficient virus replication. J. Virol. 80:8 (2006), 3872–3883.
70. Pett, M., Coleman, N., Integration of high-risk human papillomavirus: a key event in cervical carcinogenesis?. J. Pathol. 212:4 (2007), 356–367.
71. Pett, M.R., Alazawi, W.O., Roberts, I., Dowen, S., Smith, D.I., Stanley, M.A., Coleman, N., Acquisition of high-level chromosomal instability is associated with integration of human papillomavirus type 16 in cervical keratinocytes. Cancer Res. 64:4 (2004), 1359–1368.
72. Pett, M.R., Herdman, M.T., Palmer, R.D., Yeo, G.S., Shivji, M.K., Stanley, M.A., Coleman, N., Selection of cervical keratinocytes containing integrated HPV16 associates with episome loss and an endogenous antiviral response. Proc. Natl. Acad. Sci. U. S. A. 103:10 (2006), 3822–3827.
73. Poljak, M., Kocjan, B.J., Potocnik, M., Seme, K., Anogenital hairs are an important reservoir of alpha-papillomaviruses in patients with genital warts. J. Infect. Dis. 199:9 (2009), 1270–1274.
74. Potocnik, M., Kocjan, B.J., Seme, K., Luzar, B., Babic, D.Z., Poljak, M., Beta-papillomaviruses in anogenital hairs plucked from healthy individuals. J. Med. Virol. 78:12 (2006), 1673–1678.
75. Quint, K.D., Genders, R.E., de Koning, M.N., Borgogna, C., Gariglio, M., Bouwes Bavinck, J.N., Doorbar, J., Feltkamp, M.C., Human Beta-papillomavirus infection and keratinocyte carcinomas. J. Pathol. 235:2 (2015), 342–354.
76. Reidy, P.M., Dedo, H.H., Rabah, R., Field, J.B., Mathog, R.H., Gregoire, L., Lancaster, W.D., Integration of human papillomavirus type 11 in recurrent respiratory papilloma-associated cancer. The Laryngoscope 114:11 (2004), 1906–1909.
77. Ressler, S., Scheiden, R., Dreier, K., Laich, A., Muller-Holzner, E., Pircher, H., Morandell, D., Stein, I., Viertler, H.P., Santer, F.R., Widschwendter, A., Even, J., Jansen-Durr, P., Capesius, C., Zwerschke, W., High-risk human papillomavirus E7 oncoprotein detection in cervical squamous cell carcinoma. Clin. Cancer Res. 13:23 (2007), 7067–7072.
78. Roman, A., Munger, K., The papillomavirus E7 proteins. Virology 445:1–2 (2013), 138–168.
79. Roshan, A., Murai, K., Fowler, J., Simons, B.D., Nikolaidou-Neokosmidou, V., Jones, P.H., Human keratinocytes have two interconvertible modes of proliferation. Nat. Cell Biol. 18:2 (2016), 145–156.
80. Ruesch, M.N., Stubenrauch, F., Laimins, L.A., Activation of papillomavirus late gene transcription and genome amplification upon differentiation in semisolid medium is coincident with expression of involucrin and transglutaminase but not keratin-10. J. Virol. 72:6 (1998), 5016–5024.
81. Schmitt, A., Rochat, A., Zeltner, R., Borenstein, L., Barrandon, Y., Wettstein, F.O., Iftner, T., The primary target cells of the high-risk cottontail rabbit papillomavirus colocalize with hair follicle stem cells. J. Virol. 70:3 (1996), 1912–1922.
82. Simmonds, M., Storey, A., Identification of the regions of the HPV 5 E6 protein involved in Bak degradation and inhibition of apoptosis. Int. j. Cancer J. Int. du cancer 123:10 (2008), 2260–2266.
83. Spink, K.M., Laimins, L.A., Induction of the human papillomavirus type 31 late promoter requires differentiation but not DNA amplification. J. Virol. 79:8 (2005), 4918–4926.
84. Stanley, M.A., Browne, H.M., Appleby, M., Minson, A.C., Properties of a non-tumorigenic human cervical keratinocyte cell line. Int. j. Cancer J. Int. du cancer 43:4 (1989), 672–676.
85. Stanley, M., Pinto, L.A., Trimble, C., Human papillomavirus vaccines–immune responses. Vaccine 30:Suppl. 5 (2012), F83–F87.
86. Stanley, M., Immune responses to human papillomavirus. Vaccine 24:Suppl. 1 (2006), S16–S22.
87. Stanley, M.A., Epithelial cell responses to infection with human papillomavirus. Clin. Microbiol. Rev. 25:2 (2012), 215–222.
88. Sterling, J.C., Handfield-Jones, S., Hudson, P.M., Guidelines for the management of cutaneous warts. Brit. J. Dermatol. 144:1 (2001), 4–11.
89. Stoler, M.H., Wolinsky, S.M., Whitbeck, A., Broker, T.R., Chow, L.T., Differentiation-linked human papillomavirus types 6 and 11 transcription in genital condylomata revealed by in situ hybridization with message-specific RNA probes. Virology 172:1 (1989), 331–340.
90. Struijk, L., van der Meijden, E., Kazem, S., ter Schegget, J., de Gruijl, F.R., Steenbergen, R.D., Feltkamp, M.C., Specific betapapillomaviruses associated with squamous cell carcinoma of the skin inhibit UVB-induced apoptosis of primary human keratinocytes. J. Gen. Virol. 89:Pt 9 (2008), 2303–2314.
91. Tan, M.J., White, E.A., Sowa, M.E., Harper, J.W., Aster, J.C., Howley, P.M., Cutaneous beta-human papillomavirus E6 proteins bind Mastermind-like coactivators and repress Notch signaling. Proc. Natl. Acad. Sci. U. S. A. 109:23 (2012), E1473–E1480.
92. Thomas, M., Myers, M.P., Massimi, P., Guarnaccia, C., Banks, L., Analysis of multiple HPV E6 PDZ interactions defines type-specific PDZ fingerprints that predict oncogenic potential. PLoS Pathog., 12(8), 2016, e1005766.
93. Tummers, B., Burg, S.H., High-risk human papillomavirus targets crossroads in immune signaling. Viruses 7:5 (2015), 2485–2506.
94. Underbrink, M.P., Howie, H.L., Bedard, K.M., Koop, J.I., Galloway, D.A., E6 proteins from multiple human betapapillomavirus types degrade Bak and protect keratinocytes from apoptosis after UVB irradiation. J. Virol. 82:21 (2008), 10408–10417.
95. Van Doorslaer, K., Burk, R.D., Evolution of human papillomavirus carcinogenicity. Adv. Virus Res. 77 (2010), 41–62.
96. Van Doorslaer, K., Evolution of the papillomaviridae. Virology 445:1–2 (2013), 11–20.
97. Vande Pol, S.B., Klingelhutz, A.J., Papillomavirus E6 oncoproteins. Virology 445:1–2 (2013), 115–137.
98. Weissenborn, S., Neale, R.E., Waterboer, T., Abeni, D., Bavinck, J.N., Green, A.C., Harwood, C.A., Euvrard, S., Feltkamp, M.C., de Koning, M.N., Naldi, L., Quint, W.G., Tessari, G., Proby, C.M., Wieland, U., Pfister, H., group, E.-H.-U.-C., Beta-papillomavirus DNA loads in hair follicles of immunocompetent people and organ transplant recipients. Med. Microbiol. Immunol. 201:2 (2012), 117–125.
99. White, E.A., Walther, J., Javanbakht, H., Howley, P.M., Genus beta human papillomavirus E6 proteins vary in their effects on the transactivation of p53 target genes. J. Virol. 88:15 (2014), 8201–8212.
100. Woodhall, S., Ramsey, T., Cai, C., Crouch, S., Jit, M., Birks, Y., Edmunds, W.J., Newton, R., Lacey, C.J., Estimation of the impact of genital warts on health-related quality of life. Sex. Transm. Infect. 84:3 (2008), 161–166.
101. Woodhall, S.C., Jit, M., Soldan, K., Kinghorn, G., Gilson, R., Nathan, M., Ross, J.D., Lacey, C.J., group, Q.s., The impact of genital warts: loss of quality of life and cost of treatment in eight sexual health clinics in the UK. Sex. Transm. Infect. 87:6 (2011), 458–463.
102. Xue, Y., Bellanger, S., Zhang, W., Lim, D., Low, J., Lunny, D., Thierry, F., HPV16 E2 is an immediate early marker of viral infection, preceding E7 expression in precursor structures of cervical carcinoma. Cancer Res. 70:13 (2010), 5316–5325.
103. Yugawa, T., Handa, K., Narisawa-Saito, M., Ohno, S., Fujita, M., Kiyono, T., Regulation of Notch1 gene expression by p53 in epithelial cells. Mol. Cell. Biol. 27:10 (2007), 3732–3742.
104. Zhang, B., Chen, W., Roman, A., The E7 proteins of low- and high-risk human papillomaviruses share the ability to target the pRB family member p130 for degradation. Proc. Natl. Acad. Sci. U. S. A. 103:2 (2006), 437–442.
105. Zheng, S., Adachi, A., Shimizu, M., Shibata, S.I., Yasue, S., Sakakibara, A., Sugiura, M., Nagasaka, T., Tomita, Y., Human papillomaviruses of the mucosal type are present in some cases of extragenital Bowen's disease. Brit. J. Dermatol. 152:6 (2005), 1243–1247.
106. zur Hausen, H., Papillomaviruses in the causation of human cancers – a brief historical account. Virology 384:2 (2009), 260–265.